Newsfeeds
Breaking World Pharma News
World Pharma News - one of the world's leading web-based pharmaceutical news publications - is committed to providing and disseminating the most prominent pharmaceutical news and achievements.

World Pharma News
  • FDA takes action to protect consumers from potentially dangerous counterfeit medicines and devices sold online
    The U.S. Food and Drug AdministrationThe U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against more than 1,050 websites that illegally sell potentially dangerous, unapproved prescription medicines and medical devices to consumers.

  • The BMJ's data sharing policy now applies to all clinical trials
    From 1st July 2015 The BMJ requires sharing of individual patient data for all clinical trials. This means that trials will be considered for publication only if the authors agree to make the relevant anonymised patient level data available on reasonable request. The BMJ is the first general medical journal to require data sharing for all trials,

  • Citrus fruit consumption may be associated with increased melanoma risk
    A new analysis of dietary patterns among more than 100,000 Americans suggests that frequent consumption of citrus - namely whole grapefruit and orange juice - may be associated with an increased risk of melanoma. Melanoma risk was 36% higher in people who consumed citrus fruit or juice at least 1.6 times daily compared to those who consumed them less than twice per week.

  • Novartis Pharmaceuticals launches the first app for visually impaired people for use with the Apple Watch and other smart watches
    NovartisNovartis Pharmaceuticals announced the release of new features for its ViaOpta applications, and the extension for use with smart watches. The discreet, hands-free nature of using ViaOpta app with wearable devices, such as Apple Watch and Android Wear, provides users with an experience that seamlessly fits into their existing routines allowing those with visual impairments to navigate daily life with even greater ease.

  • First-ever possible treatments for MERS
    As the South Korean epidemic of Middle East Respiratory Syndrome (MERS) continues unabated, researchers have raced to find treatments for the deadly virus, which has killed more than 400 people since it was first discovered three years ago in Saudi Arabia. Now, scientists at the University of Maryland School of Medicine and Regeneron Pharmaceuticals, Inc., have discovered and validated two therapeutics that show early promise in preventing and treating the disease,

  • Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc.
    NovartisNovartis announced today that it has entered into an agreement to acquire Spinifex Pharmaceuticals, Inc. Spinifex Pharmaceuticals, Inc. is a US and Australian-based, privately held development stage company, focused on developing a peripheral approach to treat neuropathic pain such as EMA401, a novel angiotensin II Type 2 receptor (AT2R) antagonist.

  • High blood pressure linked to reduced Alzheimer's risk, meds may be reason
    A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer's disease. However, authors conclude the connection may have more to do with anti-hypertension medication than high blood pressure itself.

  • Group calls for more transparency in science research
    An international group of academic leaders, journal editors and funding-agency representatives and disciplinary leaders, including Rick Wilson, the Herbert S. Autrey Chair of Political Science and professor of statistics and psychology at Rice University, has announced guidelines to further strengthen transparency and reproducibility practices in science research reporting.

  • Medical research not addressing patient and clinician priorities
    Research on treatments for health problems, such as diabetes, stroke and schizophrenia, is not being focused on the treatments considered most important by patients and clinicians, according to a study published in the open access journal Research Involvement and Engagement. The study suggests that current research is instead favoring drug treatments over physical or psychological therapies, or interventions to improve educational approaches or service organization.

  • Generic heart disease medications offer promise for Ebola treatment
    Generic medications used frequently in the management of heart disease patients also have the potential to bolster the immune systems of patients with Ebola virus and some other life-threatening illnesses, researchers report this week in mBio®, the online open-access journal of the American Society for Microbiology.